Unknown

Dataset Information

0

Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.

ABSTRACT: Early-onset Alzheimer's disease (EOAD) represents 1%-2% of the Alzheimer's disease (AD) cases, and it is generally characterized by a positive family history and a rapidly progressive symptomatology. Rare coding and fully penetrant variants in amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) are the only causative mutations reported for autosomal dominant AD. Thus, in this study we used exome sequencing data to rapidly screen rare coding variability in APP, PSEN1, and PSEN2, in a British cohort composed of 47 unrelated EOAD cases and 179 elderly controls, neuropathologically proven. We report 2 novel and likely pathogenic variants in PSEN1 (p.L166V and p.S230R). A comprehensive catalog of rare pathogenic variants in the AD Mendelian genes is pivotal for a premortem diagnosis of autosomal dominant EOAD and for the differential diagnosis with other early onset dementias such as frontotemporal dementia (FTD) and Creutzfeldt-Jakob disease (CJD).

SUBMITTER: Sassi C 

PROVIDER: S-EPMC4099516 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Early-onset Alzheimer's disease (EOAD) represents 1%-2% of the Alzheimer's disease (AD) cases, and it is generally characterized by a positive family history and a rapidly progressive symptomatology. Rare coding and fully penetrant variants in amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) are the only causative mutations reported for autosomal dominant AD. Thus, in this study we used exome sequencing data to rapidly screen rare coding variability in APP, PSEN1,  ...[more]

Similar Datasets

Unknown Whole-exome sequencing identifies novel LEPR mutations in individuals with severe early onset obesity.
| S-EPMC3791145 | biostudies-literature
Unknown Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer's disease.
| S-EPMC8161517 | biostudies-literature
Unknown Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutation.
| S-EPMC5166571 | biostudies-literature
Unknown Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.
| S-EPMC5335658 | biostudies-other
Unknown Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome.
| S-EPMC5086082 | biostudies-literature
Unknown Exome sequencing identified null mutations in LOXL3 associated with early-onset high myopia.
| S-EPMC4764606 | biostudies-literature
Unknown Trio-based exome sequencing arrests de novo mutations in early-onset high myopia.
| S-EPMC5402409 | biostudies-literature
Unknown Exome sequencing identifies PDE4D mutations in acrodysostosis.
| S-EPMC3322224 | biostudies-literature
Unknown Exome sequencing identifies novel and known mutations in families with intellectual disability.
| S-EPMC8399827 | biostudies-literature
Unknown Whole-Exome Sequencing Identifies Novel Somatic Mutations in Chinese Breast Cancer Patients.
| S-EPMC4747093 | biostudies-literature